AdBioTech closes ₩13.3B share issue, governance overhaul puts LNJ Trust Holdings atop control chain
What's the deal? South Korean biotech firm AdBioTech (179530) has completed a ₩13.3B ($9.6M) third-party allotment share issue and announced a governance overhaul. The company issued 7.27 million new shares, with listing set for June 23. Proceeds will fund operations and business expansion.
The largest allocation — 5.99 million shares — went to BK Partners Investment Association No. 1, AdBioTech's controlling shareholder. Including previously held stock, the fund now owns roughly 9.4 million shares, or about 34.86% of the company.
On the same day, the fund's own ownership changed hands. LNJ Trust Holdings replaced EtronDealroom has a profile for this one. Try Dealroom → as its top limited partner by acquiring 100% of the fund through a ₩10.9B new capital injection and a ₩7.6B transfer of existing stakes.
Why now? AdBioTech has been pivoting beyond its core immunoantibody platform into bio R&D, healthcare, pet care, and digital platforms. The capital raise and governance reshuffle appear designed to give the company a stable financial base and clearer decision-making structure as it diversifies.
The company also plans to raise an additional ₩3B through a 10th-tranche unsecured private convertible bond, again subscribed by BK Partners, with payment due by August 31. Those funds are earmarked for acquiring stakes in other companies and expanding into new business areas.
What could go wrong? Concentrating ownership in a single fund — now wholly controlled by one entity — raises governance risk. If LNJ Trust Holdings' interests diverge from those of minority shareholders, the latter have limited recourse. The convertible bond adds further dilution risk.
Rapid diversification into unrelated sectors also carries execution risk. Spreading resources across bio R&D, pet care, and digital platforms could stretch a small-cap company thin.
The signal: AdBioTech's restructuring illustrates how thinly traded Korean micro-caps use layered financial instruments — third-party allotments followed by convertible bonds to the same subscriber — to concentrate control while funding pivot strategies. With LNJ Trust Holdings now sitting atop a single-fund ownership chain that commands nearly 35% of the company, minority shareholders are effectively betting on one controlling entity's ability to execute across at least four unrelated verticals simultaneously.
Read more: Edaily
